Hamdy Ahmed MD has filed 21 insider transactions across 2 companies since March 2024.
Most recent transaction: a transaction of 50 shares of CURIS INC ($CRIS) on March 20, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 20, 2026 | CURIS INC | $CRIS | Hamdy Ahmed MD | CMO | C | Series B Convertible Preferred Stock | 50 | $0.00 | 0.0000 | 15,680,178 | 100.00% | 0.00% |
| March 20, 2026 | CURIS INC | $CRIS | Hamdy Ahmed MD | CMO | C | Common Stock | 66667 | $0.00 | 66,667.0000 | 15,680,178 | 9999.99% | 0.43% |
| March 17, 2026 | CURIS INC | $CRIS | Hamdy Ahmed MD | CMO | A | Series B Convertible Preferred Stock | 50 | $0.00 | 50.0000 | 15,680,178 | 9999.99% | 0.00% |
| March 17, 2026 | CURIS INC | $CRIS | Hamdy Ahmed MD | CMO | A | Series C Warrant (right to buy) | 66667 | $0.00 | 66,667.0000 | 15,680,178 | 9999.99% | 0.43% |
| March 17, 2026 | CURIS INC | $CRIS | Hamdy Ahmed MD | CMO | A | Series A Warrant (right to buy) | 66667 | $0.00 | 66,667.0000 | 15,680,178 | 9999.99% | 0.43% |
| March 17, 2026 | CURIS INC | $CRIS | Hamdy Ahmed MD | CMO | A | Series B Warrant (right to buy) | 66667 | $0.00 | 66,667.0000 | 15,680,178 | 9999.99% | 0.43% |
| May 1, 2025 | CURIS INC | $CRIS | Hamdy Ahmed MD | CMO | A | Employee stock option (right to buy) | 200000 | $2.48 | 200,000.0000 | 6,306,284 | 9999.99% | 3.17% |
| Aug. 12, 2024 | Vincerx Pharma, Inc. | $VINC | Hamdy Ahmed MD | Chief Executive Officer | A | Stock Option (right to buy) | 90000 | $0.00 | 90,000.0000 | 38,339 | 9999.99% | 100.00% |
| Aug. 12, 2024 | Vincerx Pharma, Inc. | $VINC | Hamdy Ahmed MD | Chief Executive Officer | D | Stock Option (right to buy) | 146746 | $0.00 | 0.0000 | 38,339 | 100.00% | 100.00% |
| Aug. 12, 2024 | Vincerx Pharma, Inc. | $VINC | Hamdy Ahmed MD | Chief Executive Officer | A | Stock Option (right to buy) | 146746 | $0.00 | 146,746.0000 | 38,339 | 9999.99% | 100.00% |
| Aug. 12, 2024 | Vincerx Pharma, Inc. | $VINC | Hamdy Ahmed MD | Chief Executive Officer | D | Stock Option (right to buy) | 127500 | $0.00 | 0.0000 | 38,339 | 100.00% | 100.00% |
| Aug. 12, 2024 | Vincerx Pharma, Inc. | $VINC | Hamdy Ahmed MD | Chief Executive Officer | A | Stock Option (right to buy) | 53254 | $0.00 | 200,000.0000 | 38,339 | 36.29% | 100.00% |
| Aug. 12, 2024 | Vincerx Pharma, Inc. | $VINC | Hamdy Ahmed MD | Chief Executive Officer | D | Stock Option (right to buy) | 53254 | $0.00 | 0.0000 | 38,339 | 100.00% | 100.00% |
| Aug. 12, 2024 | Vincerx Pharma, Inc. | $VINC | Hamdy Ahmed MD | Chief Executive Officer | A | Stock Option (right to buy) | 127500 | $0.00 | 127,500.0000 | 38,339 | 9999.99% | 100.00% |
| Aug. 12, 2024 | Vincerx Pharma, Inc. | $VINC | Hamdy Ahmed MD | Chief Executive Officer | D | Stock Option (right to buy) | 60000 | $0.00 | 0.0000 | 38,339 | 100.00% | 100.00% |
| Aug. 12, 2024 | Vincerx Pharma, Inc. | $VINC | Hamdy Ahmed MD | Chief Executive Officer | A | Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 38,339 | 9999.99% | 100.00% |
| Aug. 12, 2024 | Vincerx Pharma, Inc. | $VINC | Hamdy Ahmed MD | Chief Executive Officer | D | Stock Option (right to buy) | 60000 | $0.00 | 0.0000 | 38,339 | 100.00% | 100.00% |
| Aug. 12, 2024 | Vincerx Pharma, Inc. | $VINC | Hamdy Ahmed MD | Chief Executive Officer | A | Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 38,339 | 9999.99% | 100.00% |
| Aug. 12, 2024 | Vincerx Pharma, Inc. | $VINC | Hamdy Ahmed MD | Chief Executive Officer | D | Stock Option (right to buy) | 90000 | $0.00 | 0.0000 | 38,339 | 100.00% | 100.00% |
| May 23, 2024 | Vincerx Pharma, Inc. | $VINC | Hamdy Ahmed MD | Chief Executive Officer | A | Stock Option (right to buy) | 53254 | $0.00 | 200,000.0000 | 1,085 | 36.29% | 100.00% |
| March 7, 2024 | Vincerx Pharma, Inc. | $VINC | Hamdy Ahmed MD | Chief Executive Officer | A | Stock Option (right to buy) | 146746 | $0.00 | 146,746.0000 | 1,065 | 9999.99% | 100.00% |